TrialBMC cancer2023

Dynamic profiling of immune microenvironment during anti-PD-1 immunotherapy for head and neck squamous cell carcinoma: the IPRICE study.

Carinato Hélène et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.